Loading...

CNTX CONTEXT THERAPEUTICS INC Management Changes 8-K Filing

CNTX

CNTX

CONTEXT THERAPEUTICS INC

(CNTX)

2025 8-K

Summary

Summary

Nasdaq Extension Granted

Reverse Stock Split

Investor Meetings

Clinical Trial Update

Nasdaq Notification

Clinical Trial Update

License Agreement

Board Appointments

Annual Meeting of Stockholders

Private Placement

FDA IND Application Submission

Bylaws Amendment

Amendment of Collaboration ...

Press Release and Corporate...

Regulation FD Disclosure

Compliance with Minimum Bid...

Annual Meeting of Stockholders

Financial Results and Disco...

Regulation FD Disclosure

Press Release and Corporate...

External Links:

Richard Berman resigned from the Board of Directors of Context Therapeutics Inc., and Andy Pasternak was appointed as the new Chairperson of the Board, effective January 13, 2025, with options to purchase 20,685 shares of common stock.

AI Assistant

CONTEXT THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.